Quick Answer
PALISADE BIO, INC. reported R&D Expense of $2.02 million for fiscal year 2020.
PALISADE BIO, INC. R&D Expense — Annual History
| Fiscal Year | R&D Expense | YoY Change |
|---|---|---|
| 2020 | $2.02M | -50.3% |
| 2019 | $4.06M | +2.6% |
| 2018 | $3.96M | -51.1% |
| 2017 | $8.10M | -38.5% |
| 2016 | $13.16M | +4.1% |
| 2015 | $12.64M | +51.1% |
| 2014 | $8.36M | +14.8% |
| 2013 | $7.29M | +19.3% |
| 2012 | $6.11M | -17.0% |
| 2011 | $7.35M | -19.7% |
| 2010 | $9.16M | +71.4% |
| 2009 | $5.35M | — |
Quarterly R&D Expense
| Quarter Ending | R&D Expense | YoY | QoQ |
|---|---|---|---|
| March 31, 2021 | $471.1K | -32.4% | +1.1% |
| September 30, 2020 | $466.0K | -43.5% | +4.5% |
| June 30, 2020 | $446.0K | -53.3% | -36.0% |
| March 31, 2020 | $696.9K | -54.0% | -15.6% |
| September 30, 2019 | $825.5K | -8.0% | -13.5% |
| June 30, 2019 | $954.5K | -5.9% | -37.0% |
| March 31, 2019 | $1.51M | +29.5% | +68.8% |
| September 30, 2018 | $897.1K | -35.2% | -11.6% |
- PALISADE BIO, INC. showed a decrease of -50.3% in R&D Expense compared to the prior fiscal year.
- Over the 2009–2020 period, PALISADE BIO, INC.’s r&d expense has declined by 62.3% (from $5.35 million to $2.02 million).
- The most recent figure is from PALISADE BIO, INC.’s fiscal year 2020 report (Form 10-K), filed with the SEC on March 22, 2021.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: